SABCS 2022 Meeting News Preview - 8

The Parsortix®
PC1 Clinical System
Small but powerful. Simple but versatile.
The first FDA cleared medical device
for the capture and harvest of circulating tumor
cells (CTCs) from metastatic breast cancer patient
blood for subsequent, user-validated analysis.
Visit Booth 929 to discover the potential of CTCs
with the power of Parsortix®
technology.
www.angleplc.com
https://angleplc.com/parsortix-pc1-clinical-system/

SABCS 2022 Meeting News Preview

Table of Contents for the Digital Edition of SABCS 2022 Meeting News Preview

SABCS 2022 Meeting News Preview - 1
SABCS 2022 Meeting News Preview - 2A
SABCS 2022 Meeting News Preview - 3
SABCS 2022 Meeting News Preview - 4
SABCS 2022 Meeting News Preview - 5
SABCS 2022 Meeting News Preview - 6
SABCS 2022 Meeting News Preview - 7A
SABCS 2022 Meeting News Preview - 8
SABCS 2022 Meeting News Preview - Insert-1
SABCS 2022 Meeting News Preview - Insert-2
SABCS 2022 Meeting News Preview - 9
https://www.nxtbookmedia.com